Mineralys Therapeutics Overview
Mineralys Therapeutics Discounted Cash Flow
DCF Analysis for MLYS.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.56
Current Fair Value
$2.56
↓ 89.2% Downside
Overvalued by 89.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison